SOX2 and esophageal cancer: Further exploring the effects of stem signatures-associated antibodies on tumour immune response, P53, SOX2, and PGP9.5 are not only highly expressed in esophageal cancer patients, but also act as immune activators which regulate the immune system microenvironment and selectively action potential checkpoint blockade.